PLYX
Polaryx Therapeutics, Inc.
2.00$
-2.4%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
Polaryx Therapeutics, Inc. (PLYX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -3.9 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| -0.2 | -2.6 | -3.9 | |
| 3.2 | 2.4 | 4.7 | |
| 0.4 | -0.6 | 0.3 | |
| 0.0 | 0.0 | 0.0 | |
| 0.1 | -0.1 | 0.0 | |
| 0.1 | 7.2 | 4.5 | |
| 0.0 | 4.6 | 0.5 | |
| -0.2 | -2.6 | -3.9 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.